文献速递临床生化质量管理与危急值

三种临床化学分析仪血清指数测量的精密度、准确度、交叉反应与可比性验证

Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c8000, Beckman Coulter AU5800 and Roche Cobas 6000 c501 clinical chemistry analyzers.
PubMed 文献 · Clin Chem Lab Med · 2018-01-01

研究在Abbott Architect c8000、Beckman Coulter AU5800和Roche Cobas 6000 c501上验证血清指数(HIL)的分析性能。结果显示H指数精密度最佳(0.72%-2.08%),准确度在Cobas和BC可接受而Architect高浓度区有偏差;L指数准确度均可接受但I指数均不可接受;H指数BC与Architect及Roche可比,I指数所有组合均不可比。结论认为分析仪间HIL质量性能存在异质性,常规工作中需验证血清指数。

要点

  • H指数精密度最佳,范围0.72%-2.08%。
  • I指数准确度在所有分析仪上均不可接受。
  • H指数仅BC与Architect及Roche可比,I指数均不可比。

核心结论

  • 三种分析仪在溶血、黄疸、脂血(HIL)质量性能上存在异质性。
  • 常规工作中验证血清指数是必要的,以建立分析规格。

研究设计与样本

  • 在Abbott Architect c8000、Beckman Coulter AU5800和Roche Cobas 6000 c501三种分析仪上验证血清指数。
  • 验证指标包括精密度(两个患者样本)、准确度(最高干扰物浓度样本系列稀释后与理论值比较)、可比性(120例患者样本)和交叉反应(加入干扰物前后测量)。

主要发现

  • H指数精密度最佳,范围为0.72%-2.08%。
  • H指数准确度在Cobas和BC可接受,Architect在高浓度范围出现偏差(y=0.02 [0.01-0.07]+1.07 [1.06-1.08]x)。
  • L指数准确度在所有分析仪上可接受,I指数准确度均不可接受。
  • H指数在BC与Architect(Cohen's κ [95% CI]=0.795 [0.692-0.898])及Roche(Cohen's κ [95% CI]=0.825 [0.729-0.922])间可比,Roche与Architect不可比。
  • I指数在所有分析仪组合间均不可比,L指数仅在Abbott与BC间可比;交叉反应分析显示联合干扰存在时血清指数测量受影响。

关键数值与推荐

  • H指数精密度范围为0.72%-2.08%。
  • H指数准确度Architect偏差方程:y=0.02 [0.01-0.07]+1.07 [1.06-1.08]x。
  • H指数可比性Cohen's κ [95% CI]:BC与Architect为0.795 [0.692-0.898],BC与Roche为0.825 [0.729-0.922]。

临床怎么用

  • 临床实验室应在本室常规工作中验证血清指数,以建立适合的分析规格。
  • 注意分析仪间HIL性能差异,尤其I指数准确度不可接受且不可比。

局限性

  • 研究仅纳入三种分析仪,结论外推需谨慎。
  • 交叉反应分析显示联合干扰存在时测量受影响,但未进一步量化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of our study was to perform verification of serum indices on three clinical chemistry platforms. METHODS: This study was done on three analyzers: Abbott Architect c8000, Beckman Coulter AU5800 (BC) and Roche Cobas 6000 c501. The following analytical specifications were verified: precision (two patient samples), accuracy (sample with the highest concentration of interferent was serially diluted and measured values compared to theoretical values), comparability (120 patients samples) and cross reactivity (samples with increasing concentrations of interferent were divided in two aliquots and remaining interferents were added in each aliquot. Measurements were done before and after adding interferents). RESULTS: Best results for precision were obtained for the H index (0.72%-2.08%). Accuracy for the H index was acceptable for Cobas and BC, while on Architect, deviations in the high concentration range were observed (y=0.02 [0.01-0.07]+1.07 [1.06-1.08]x). All three analyzers showed acceptable results in evaluating accuracy of L index and unacceptable results for I index. The H index was comparable between BC and both, Architect (Cohen's κ [95% CI]=0.795 [0.692-0.898]) and Roche (Cohen's κ [95% CI]=0.825 [0.729-0.922]), while Roche and Architect were not comparable. The I index was not comparable between all analyzer combinations, while the L index was only comparable between Abbott and BC. Cross reactivity analysis mostly showed that serum indices measurement is affected when a combination of interferences is present. CONCLUSIONS: There is heterogeneity between analyzers in the hemolysis, icteria, lipemia (HIL) quality performance. Verification of serum indices in routine work is necessary to establish analytical specifications.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Nikolac Gabaj N, Miler M, Vrtarić A, et al. Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c8000, Beckman Coulter AU5800 and Roche Cobas 6000 c501 clinical chemistry analyzers. Clin Chem Lab Med. 2018. PMID: 29315074. doi:10.1515/cclm-2017-0889

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。